- Corporate Officers - Q
- Quinn Anthony G.
Insider Trading History of Quinn Anthony G.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Quinn Anthony G. since 2012.
This trader's CIK number is 1532219.
At the time of last reporting, Quinn Anthony G. was the Officer of Generation Bio Co.. (stock ticker symbol GBIO).
Also see all insider trading activities at Generation Bio Co..
Note that in the past
Quinn Anthony G. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Generation Bio Co. (GBIO) by Quinn Anthony G.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | GBIO | 210,791 | $203,209 | 0 | $0 | 0 | $0 |
2023 | GBIO | 88,495 | $124,777 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Trimeris Inc (GEVA) by Quinn Anthony G.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | GEVA | 0 | $0 | 59,503 | $5,996,201 | 39,503 | $657,948 |
2014 | GEVA | 0 | $0 | 30,000 | $2,396,949 | 40,000 | $479,000 |
2013 | GEVA | 0 | $0 | 15,000 | $751,129 | 10,000 | $9,499 |
2012 | GEVA | 0 | $0 | 36,000 | $1,558,378 | 10,000 | $9,500 |
Yearly summary of insider trading at Spyre Therapeutics, Inc. (AGLE) by Quinn Anthony G.
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | AGLE | 224,745 | $468,642 | 0 | $0 | 0 | $0 |
2021 | AGLE | 53,634 | $198,971 | 0 | $0 | 0 | $0 |
2020 | AGLE | 165,000 | $783,750 | 0 | $0 | 0 | $0 |
2019 | AGLE | 77,210 | $502,896 | 0 | $0 | 27,021 | $159,018 |
2018 | AGLE | 2,994 | $21,115 | 0 | $0 | 229,274 | $1,270,351 |
2017 | AGLE | 25,409 | $124,250 | 0 | $0 | 0 | $0 |
2016 | AGLE | 10,000 | $100,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Quinn Anthony G.:
1. Generation Bio Co. (GBIO)
2. Trimeris Inc (GEVA)
3. Spyre Therapeutics, Inc. (AGLE)
Table 1. Insider trading of Generation Bio Co. (GBIO) by Quinn Anthony G.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-01-13 | GBIO | Buy | 85,000 | .97 | 82,450 |
2025-01-10 | GBIO | Buy | 125,791 | .96 | 120,759 |
2023-12-01 | GBIO | Buy | 88,495 | 1.41 | 124,777 |
Table 2. Insider trading of Trimeris Inc (GEVA) by Quinn Anthony G.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-04-27 | GEVA | Option Ex | 10,000 | 1.70 | 17,000 |
2015-04-27 | GEVA | Sale | 10,000 | 110.00 | 1,100,000 |
2015-04-21 | GEVA | Sale | 10,000 | 108.00 | 1,080,000 |
2015-04-15 | GEVA | Option Ex | 10,000 | 40.74 | 407,400 |
2015-04-15 | GEVA | Sale | 10,000 | 105.00 | 1,050,000 |
2015-04-06 | GEVA | Option Ex | 19,503 | 11.97 | 233,548 |
2015-04-06 | GEVA | Sale | 29,503 | 93.76 | 2,766,201 |
2014-09-02 | GEVA | Sale | 10,000 | 71.31 | 713,050 |
2014-09-02 | GEVA | Option Ex | 10,000 | 23.00 | 230,000 |
2014-04-01 | GEVA | Sale | 20,000 | 84.19 | 1,683,899 |
2014-04-01 | GEVA | Option Ex | 20,000 | 11.97 | 239,500 |
2014-04-01 | GEVA | Option Ex | 10,000 | .95 | 9,500 |
2013-01-18 | GEVA | Option Ex | 9,447 | .95 | 8,974 |
2013-01-18 | GEVA | Sale | 9,447 | 50.08 | 473,105 |
2013-01-16 | GEVA | Option Ex | 353 | .95 | 335 |
2013-01-17 | GEVA | Option Ex | 200 | .95 | 190 |
2013-01-16 | GEVA | Sale | 5,353 | 50.07 | 268,024 |
2013-01-17 | GEVA | Sale | 200 | 50.00 | 10,000 |
2012-07-26 | GEVA | Option Ex | 1,100 | .95 | 1,045 |
2012-07-27 | GEVA | Sale | 6,400 | 50.23 | 321,504 |
2012-07-27 | GEVA | Option Ex | 6,400 | .95 | 6,080 |
2012-07-26 | GEVA | Sale | 1,100 | 50.00 | 55,000 |
2012-07-19 | GEVA | Option Ex | 1,900 | .95 | 1,805 |
2012-07-20 | GEVA | Option Ex | 600 | .95 | 570 |
2012-07-19 | GEVA | Sale | 1,900 | 50.00 | 95,000 |
2012-07-20 | GEVA | Sale | 600 | 50.00 | 30,000 |
2012-06-25 | GEVA | Sale | 26,000 | 40.65 | 1,056,874 |
Table 3. Insider trading of Spyre Therapeutics, Inc. (AGLE) by Quinn Anthony G.
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-03-16 | AGLE | Buy | 80,079 | 2.34 | 187,705 |
2022-03-14 | AGLE | Buy | 67,472 | 1.93 | 130,220 |
2022-03-15 | AGLE | Buy | 42,417 | 1.86 | 78,938 |
2022-03-11 | AGLE | Buy | 34,777 | 2.06 | 71,779 |
2021-12-10 | AGLE | Buy | 10,526 | 3.75 | 39,472 |
2021-12-09 | AGLE | Buy | 43,108 | 3.70 | 159,499 |
2020-04-30 | AGLE | Buy | 165,000 | 4.75 | 783,750 |
2019-10-04 | AGLE | Option Ex | 18,265 | 5.88 | 107,489 |
2019-06-12 | AGLE | Buy | 12,217 | 6.12 | 74,706 |
2019-06-13 | AGLE | Buy | 14,406 | 6.17 | 88,841 |
2019-06-14 | AGLE | Buy | 5,282 | 6.23 | 32,912 |
2019-05-20 | AGLE | Buy | 8,989 | 6.55 | 58,922 |
2019-05-22 | AGLE | Buy | 3,809 | 6.86 | 26,129 |
2019-05-21 | AGLE | Buy | 13,794 | 6.89 | 94,985 |
2019-05-15 | AGLE | Buy | 6,256 | 6.76 | 42,271 |
2019-05-16 | AGLE | Buy | 5,520 | 6.83 | 37,690 |
2019-02-15 | AGLE | Buy | 719 | 7.10 | 5,103 |
2019-05-17 | AGLE | Buy | 6,218 | 6.65 | 41,337 |
2019-02-06 | AGLE | Option Ex | 8,756 | 5.88 | 51,529 |
2018-08-15 | AGLE | Buy | 994 | 9.13 | 9,075 |
2018-12-07 | AGLE | Option Ex | 171,890 | 5.29 | 909,813 |
2018-02-15 | AGLE | Buy | 2,000 | 6.02 | 12,040 |
2018-07-12 | AGLE | Option Ex | 38,866 | 6.67 | 259,430 |
2018-07-11 | AGLE | Option Ex | 3,307 | 5.46 | 18,056 |
2018-02-15 | AGLE | Option Ex | 15,211 | 5.46 | 83,052 |
2017-12-06 | AGLE | Buy | 4,888 | 4.92 | 24,073 |
2017-12-07 | AGLE | Buy | 2,800 | 4.99 | 13,966 |
2017-12-08 | AGLE | Buy | 600 | 5.07 | 3,039 |
2017-12-05 | AGLE | Buy | 5,065 | 4.93 | 24,975 |
2017-12-01 | AGLE | Buy | 4,100 | 4.53 | 18,577 |
2017-12-04 | AGLE | Buy | 7,956 | 4.98 | 39,620 |
2016-04-12 | AGLE | Buy | 10,000 | 10.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Quinn Anthony G.
(Officer of Generation Bio Co. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.